These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4669354)

  • 1. [Persistence of anti-V hemagglutination-inhibiting antibodies and complement-fixing antibodies induced by administration of inactivated influenza vaccines].
    Profeta ML
    Ann Sclavo; 1972; 14(2):145-58. PubMed ID: 4669354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antibody response after anti-influenza vaccination in a closed community and protective effect against the disease].
    Scalise G; Maida A; Mura MS; Pettinato S; Mura M
    Ann Sclavo; 1974; 16(3):243-60. PubMed ID: 4429406
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vaccination of children against influenza].
    Pressler K; Sattler HJ; Schöck V
    Z Kinderheilkd; 1975; 118(4):265-9. PubMed ID: 1130119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibody determination following influenza vaccination].
    Wegmann A
    Ther Umsch; 1972 Dec; 29(12):747-9. PubMed ID: 4639117
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of neutralizing, haemagglutination-inhibiting and strain-specific complement-fixing antibodies in guinea pigs given inactivated influenza vaccine.
    Závadová H; Vonka V
    Acta Virol; 1968 Mar; 12(2):151-6. PubMed ID: 4384403
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antiviral inhibitors and antibodies in the serum of subjects vaccinated against influenza].
    Kazakova VN; Kupriashina LM
    Vopr Virusol; 1971; 16(6):651-5. PubMed ID: 5141610
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemagglutination inhibition reaction as an indicator of humoral immunity in influenza: limitations of the method].
    Zaĭdes VM; Zhdanov VM
    Vopr Virusol; 1984; 29(1):4-8. PubMed ID: 6369785
    [No Abstract]   [Full Text] [Related]  

  • 10. [Complement fixation, hemagglutination inhibition and neuraminidase inhibition reactions in the seroepidemiologic evaluation of an influenza A epidemic].
    Volpi A; Ragona G; Gentile R; Cervelli G; De Felici A; Muzzi A
    Boll Ist Sieroter Milan; 1976 Sep; 55(4):287-91. PubMed ID: 1016581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of influenza antibody titers in enzyme immunoassays and other serologic reactions following preventive vaccination and in influenza patients].
    Schmidt J; Adamczyk B; Gruhn I; Oehring H; Süss J; Vogt KH; Brunnemann H; Michaelis I; Schmidt S; Kittlick M
    Z Gesamte Hyg; 1984 Aug; 30(8):436-41. PubMed ID: 6385499
    [No Abstract]   [Full Text] [Related]  

  • 12. Nasal and circulating antibody responses to influenza vaccination and their importance in resistance to infection.
    Tyrrell DA; Buckland RA; Schild GC; Freestone DS; Chinn S; Slepushkin AN
    Postgrad Med J; 1973 Mar; 49(569):200-2. PubMed ID: 4802537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of the radial hemolysis method for determining influenza virus antibodies in human sera].
    Demidova SA
    Vopr Virusol; 1980; (6):731-5. PubMed ID: 7013275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of antibody responses to natural influenza infection or vaccination by single radial haemolysis test.
    Creţescu L; Zilisteanu E; Niculescu IT; Crainic R
    Arch Roum Pathol Exp Microbiol; 1979; 38(1):77-80. PubMed ID: 397807
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative evaluation of immunofluorescent (IgM and IgG) and complement-fixing antibodies in influenza A infection.
    Masihi KN; Köhler H; Lange W
    Zentralbl Bakteriol Orig A; 1979 Jun; 244(1):17-24. PubMed ID: 388933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic lymphatic pumping and the efficacy of influenza vaccination in healthy young and elderly populations.
    Breithaupt T; Harris K; Ellis J; Purcell E; Weir J; Clothier M; Boesler D
    J Am Osteopath Assoc; 2001 Jan; 101(1):21-5. PubMed ID: 11234217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killed subunit influenza vaccine in children.
    Phillips CF; Phillips CA; Hodgkin WE; Forsyth BR; Rubin BA; Geraghty ME
    Pediatrics; 1973 Sep; 52(3):416-9. PubMed ID: 4738294
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum IgM antibody and influenza A infection.
    Buchner YI; Heath RB; Collins JV; Pattison JR
    J Clin Pathol; 1977 Aug; 30(8):723-7. PubMed ID: 599186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.